Current noninvasive imaging techniques for detection of coronary artery disease

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 1, 2010, Pages 77-91

  Mastouri, Ronald ^a   Sawada, Stephen G ^a   Mahenthiran, Jo ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

coronary artery disease; diagnosis; noninvasive cardiac imaging; stress testing

Indexed keywords

ADENOSINE; ATROPINE; DIPYRIDAMOLE; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOISOTOPE; RUBIDIUM 82; TECHNETIUM 99M; THALLIUM 201;

ANGIOCARDIOGRAPHY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DRUG MEGADOSE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GLOMERULUS FILTRATION RATE; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART STRESS; HEART VENTRICLE CONTRACTION; HEART VENTRICLE WALL MOTION; HUMAN; LOW DRUG DOSE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDIAL PERFUSION IMAGING; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSTIC EQUIPMENT AND SUPPLIES; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; THORAX RADIOGRAPHY; TREADMILL EXERCISE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; ECONOMICS; METHODOLOGY; PATHOLOGY;

CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY, STRESS; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77949531483     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.164     Document Type: Review

References (86)

1. Thom T, Kannel WB, Silbershatz S et al. Incidence, Prevalence, and Mortality of Cardiovascular Diseases in the United States. Alexander R, Schlant RC, Fuster V, Roberts R (Eds). McGraw Hill, NY, USA (1998).
2. Kannel WB. Prevalence and clinical aspects of unrecognized myocardial infarction and sudden unexpected death. Circulation 75(3 Pt 2), 114-115 (1987).
3. Ford ES, Ajani UA, Croft JB et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N. Engl. J. Med. 356(23), 2388-2398 (2007).
4. Weiner DA, Ryan TJ, McCabe CH et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J. Am. Coll. Cardiol. 3(3), 772-779 (1984).
5. Lerakis S, Aznaouridis K, Synetos A et al. Predictive value of normal dobutamine stress echocardiogram in patients with low-risk acute chest pain. Int. J. Cardiol. D0I:10.1016/j.ijcard.2009.02.013 (2009) (Epub ahead of print).
6. Lerakis S, McLean DS, Anadiotis AV et al. Prognostic value of adenosine stress cardiovascular magnetic resonance in patients with low-risk chest pain. J. Cardiovasc. Magn. Reson. 11(1), 37 (2009).
7. Grondin CM, Dyrda I, Pasternac A, Campeau L, Bourassa MG, Lesperance J. Discrepancies between cineangiographic and postmortem findings in patients with coronary artery disease and recent myocardial revascularization. Circulation 49(4), 703-708 (1974).
8. Roberts WC, Jones AA. Quantitation of coronary arterial narrowing at necropsy in sudden coronary death: analysis of 31 patients and comparison with 25 control subjects. Am. J. Cardiol. 44(1), 39-45 (1979).
9. Hansing CE. The risk and cost of coronary angiography. II. The risk of coronary angiography in Washington State. JA MA 242(8), 735-738 (1979).
10. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J. Am. Soc. Echocardiogr. 2(5), 358-367 (1989).
11. Cerqueira MD, Weissman NJ, Dilsizian V et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105(4), 539-542 (2002).
12. Marwick TH. Stress echocardiography. Heart 89(1), 113-118 (2003).
13. Mieres JH, Shaw LJ, Arai A et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 111(5), 682-696 (2005).
14. Marwick T, D'Hondt AM, Baudhuin T et al. 0ptimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J. Am. Coll. Cardiol. 22(1), 159-167 (1993).
15. Secknus MA, Marwick TH. Influence of gender on physiologic response and accuracy of dobutamine echocardiography. Am. J. Cardiol. 80(6), 721-724 (1997).
16. Shehata AR, Gillam LD, Mascitelli VA et al. Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. Am. J. Cardiol. 80(3), 268-272 (1997).
17. Smart SC, Knickelbine T, Malik F, Sagar KB. Dobutamine-atropine stress echocardiography for the detection of coronary artery disease in patients with left ventricular hypertrophy. Importance of chamber size and systolic wall stress. Circulation 101(3), 258-263 (2000).
18. Bach DS, Muller DW, Gros BJ, Armstrong WF. False positive dobutamine stress echocardiograms: characterization of clinical, echocardiographic and angiographic findings. J. Am. Coll. Cardiol. 24(4), 928-933 (1994).
19. Fragasso G, Lu C, Dabrowski P, Pagnotta P, Sheiban I, Chierchia SL. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. J. Am. Coll. Cardiol. 34(2), 441-447 (1999).
20. Aboukhoudir F, Rekik S, Andrieu S et al. Coronary artery spasm and dobutamine stress echocardiography. Eur. J. Echocardiogr. 10(4), 556-561 (2009).
21. Cheitlin MD, Armstrong WF, Aurigemma GP et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/ AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 108(9), 1146-1162 (2003).
22. Rainbird AJ, Mulvagh SL, Oh JK et al. Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients. J. Am. Soc. Echocardiogr. 14(5), 378-385 (2001).
23. Dolan MS, Gala SS, Dodla S et al. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J. Am. Coll. Cardiol. 53(1), 32-38 (2009).
24. Hoffmann R, Lethen H, Marwick T et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J. Am. Coll. Cardiol. 27(2), 330-336 (1996).
25. Heijenbrok-Kal MH, Fleischmann KE, Hunink MG. Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. Am. Heart J. 154(3), 415-423 (2007).
26. Beller GA. Radionuclide exercise testing for coronary artery disease. Cardiol. Clin. 2(3), 367-378 (1984).
27. Osbakken MD, Okada RD, Boucher CA, Strauss HW, Pohost GM. Comparison of exercise perfusion and ventricular function imaging: an analysis of factors affecting the diagnostic accuracy of each technique. J. Am. Coll. Cardiol. 3(2 Pt 1), 272-283 (1984).
28. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of Tl201 and Tc99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J. Am. Coll. Cardiol. 29(1), 69-77 (1997).
29. Mieres JH, Shaw LJ, Hendel RC et al. American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease - the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction]. J. Nucl. Cardiol. 10(1), 95-101 (2003).
30. Sharir T, Rabinowitz B, Livschitz S et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J. Am. Coll. Cardiol. 31(7), 1540-1546 (1998).
31. Klocke FJ, Baird MG, Lorell BH et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 108(11), 1404-1418 (2003).
32. DePuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J. Nucl. Med. 36(6),952-955 (1995).
33. Machac J. Cardiac positron emission tomography imaging. Semin. Nucl. Med. 35(1), 17-36 (2005).
34. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur SR, Reddy P, Carlos RC. Diagnostic performance of positron emission tomography in the detection of coronary artery disease: a meta-analysis. Acad. Radiol. 15(4), 444-451 (2008).
35. Go RT, Marwick TH, Maclntyre WJ et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J. Nucl. Med. 31(12), 1899-1905 (1990).
36. Stewart RE, Schwaiger M, Molina E et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am. J. Cardiol. 67(16), 1303-1310 (1991).
37. Patterson RE, Churchwell KB, Eisner RL. Diagnosis of coronary artery disease in women: roles of three dimensional imaging with magnetic resonance or positron emission tomography. Am. J. Card. Imaging 10(1), 78-88 (1996).
38. Bateman TM, Heller GV, McGhie AI et al. Diagnostic accuracy of rest/stress ECG- gated Rb82 myocardial perfusion PET: comparison with ECG-gated Tc99m sestamibi SPECT. J. Nucl. Cardiol. 13(1), 24-33 (2006).
39. Patterson RE, Cloninger K, Churchwell KB et al. Special problems with cardiovascular imaging in women. In: Women and Heart Disease. Julian DG, Wenger NK (Eds.) Martin Dunitz Ltd, London, UK, 91 (1997).
40. Ogawa M, Ishino S, Mukai T et al. F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J. Nucl. Med. 45(7), 1245-1250 (2004).
41. Tawakol A, Migrino RQ, Bashian GG et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J. Am. Coll. Cardiol. 48(9), 1818-1824 (2006).
42. Sampson UK, Dorbala S, Limaye A, Kwong R, Di Carli MF. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J. Am. Coll. Cardiol. 49(10), 1052-1058 (2007).
43. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J. Am. Coll. Cardiol. 50(14), 1343-1353 (2007).
44. Geskin G, Kramer CM, Rogers WJ et al. Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 98(3), 217-223 (1998).
45. Wolff SD, Schwitter J, Coulden R et al. Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation 110(6), 732-737 (2004).
46. Nagel E, Klein C, Paetsch I et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 108(4), 432-437 (2003).
47. Plein S, Greenwood JP, Ridgway JP, Cranny G, Ball SG, Sivananthan MU. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J. Am. Coll. Cardiol. 44(11), 2173-2181 (2004).
48. Nagel E, Lehmkuhl HB, Bocksch W et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99(6), 763-770 (1999).
49. Keijer JT, van Rossum AC, van Eenige MJ et al. Magnetic resonance imaging of regional myocardial perfusion in patients with single-vessel coronary artery disease: quantitative comparison with 201Thallium- SPECT and coronary angiography. J. Magn. Reson. Imaging 11(6), 607-615 (2000).
50. Panting JR, Gatehouse PD, Yang GZ et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N. Engl. J. Med. 346(25), 1948-1953 (2002).
51. Danias PG, Roussakis A, Ioannidis JP. Diagnostic performance of coronary magnetic resonance angiography as compared against conventional x-ray angiography: a meta-analysis. J. Am. Coll. Cardiol. 44(9), 1867-1876 (2004).
52. Bellenger NG, Burgess MI, Ray SG et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur. Heart J. 21(16), 1387-1396 (2000).
53. Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am. Heart J.147:(2)218-223(2004).
54. Kim WY, Danias PG, Stuber M et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N. Engl. J. Med. 345(26), 1863-1869 (2001). (Pubitemid 33716560)
55. Moshage WE, Achenbach S, Seese B, Bachmann K, Kirchgeorg M. Coronary artery stenoses: three-dimensional imaging with electrocardiographically triggered, contrast agent-enhanced, electron-beam CT. Radiology 196(3), 707-714 (1995).
56. Flohr TG, McCollough CH, Bruder H et al. First performance evaluation of a dual-source CT (DSCT) system. Eur. Radiol. 16(2), 256-268 (2006).
57. Raff GL, Abidov A, Achenbach S et al. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J. Cardiovasc. Comput. Tomogr. 3(2), 122-136 (2009).
58. Schuijf JD, Bax JJ, Shaw LJ et al. Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multislice computed tomography for noninvasive coronary angiography. Am. Heart J. 151(2), 404-411 (2006).
59. Miller JM, Rochitte CE, Dewey M et al. Diagnostic performance of coronary angiography by 64-row CT. N. Engl. J. Med. 359(22), 2324-2336 (2008).
60. Abdulla J, Abildstrom SZ, Gotzsche O, Christensen E, Kober L, Torp-Pedersen C. 64-multislice detector computed tomography coronary angiography as potential alternative to conventional coronary angiography: a systematic review and meta-analysis. Eur. Heart J. 28(24), 3042-3050 (2007).
61. Stein PD, Yaekoub AY, Matta F, Sostman HD. 64-slice CT for diagnosis of coronary artery disease: a systematic review. Am. J. Med. 121(8), 715-725 (2008).
62. Budoff MJ, Dowe D, Jollis JG et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J. Am. Coll. Cardiol. 52(21), 1724-1732 (2008).
63. Pundziute G, Schuijf JD, Jukema JW et al. Gender influence on the diagnostic accuracy of 64-slice multislice computed tomography coronary angiography for detection of obstructive coronary artery disease. Heart 94(1), 48-52 (2008).
64. Iskandrian AE. Detecting coronary artery disease in left bundle branch block. J. Am. Coll. Cardiol. 48(10), 1935-1937 (2006).
65. Ghostine S, Caussin C, Habis M et al. Non-invasive diagnosis of ischaemic heart failure using 64-slice computed tomography. Eur. Heart J. 29(17), 2133-2140 (2008).
66. Sharp SM, Sawada SG, Segar DS et al. Dobutamine stress echocardiography: detection of coronary artery disease in patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. 24(4), 934-939 (1994).
67. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15(4), 827-832 (1990).
68. Haberl R, Becker A, Leber A et al. Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients. J. Am. Coll. Cardiol. 37(2), 451-457 (2001).
69. Budoff MJ, Georgiou D, Brody A et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation 93(5), 898-904 (1996).
70. Nallamothu BK, Saint S, Bielak LF et al. Electron-beam computed tomography in the diagnosis of coronary artery disease: a meta-analysis. Arch. Intern. Med. 161(6), 833-838 (2001). (Pubitemid 32225391)
71. Nasir K, Michos ED, Blumenthal RS, Raggi P. Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. J. Am. Coll. Cardiol. 46(10), 1931-1936 (2005).
72. Park R, Detrano R, Xiang M et al. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 106(16), 2073-2077 (2002).
73. Clouse ME. How useful is computed tomography for screening for coronary artery disease? Noninvasive screening for coronary artery disease with computed tomography is useful. Circulation 113(1), 125-146; discussion 125-146 (2006).
74. Budoff MJ, Shavelle DM, Lamont DH et al. Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy. J. Am. Coll. Cardiol. 32(5), 1173-1178 (1998).
75. McLaughlin VV, Balogh T, Rich S. Utility of electron beam computed tomography to stratify patients presenting to the emergency room with chest pain. Am. J. Cardiol. 84(3), 327-328, A328 (1999).
76. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA 298(3), 317-323 (2007).
77. Hausleiter J, Meyer T, Hadamitzky M et al. Radiation dose estimates from cardiac multislice computed tomography in daily practice: impact of different scanning protocols on effective dose estimates. Circulation 113(10), 1305-1310 (2006).
78. Namdar M, Hany TF, Koepfli P et al. Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. J. Nucl. Med. 46(6), 930-935 (2005).
79. Sicari R, Pingitore A, Aquaro G, Pasanisi EG, Lombardi M, Picano E. Cardiac functional stress imaging: a sequential approach with stress echo and cardiovascular magnetic resonance. Cardiovasc. Ultrasound 5, 47 (2007).
80. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 92(3), 657-671 (1995).
81. Mann JM, Davies MJ. Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. Circulation 94(5), 928-931 (1996).
82. Schroeder S, Kopp AF, Baumbach A et al. Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J. Am. Coll. Cardiol. 37(5), 1430-1435 (2001).
83. Achenbach S, Moselewski F, Ropers D et al. Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation 109(1), 14-17 (2004). (Pubitemid 38056013)
84. Komatsu S, Hirayama A, Omori Y et al. Detection of coronary plaque by computed tomography with a novel plaque analysis system, 'plaque map', and comparison with intravascular ultrasound and angioscopy. Circ. J. 69(1), 72-77 (2005).
85. Kawasaki T, Koga S, Koga N et al. Characterization of hyperintense plaque with noncontrast T(1)-weighted cardiac magnetic resonance coronary plaque imaging: comparison with multislice computed tomography and intravascular ultrasound. JACC Cardiovasc. Imaging 2(6), 720-728 (2009).
86. Gerber TC, Carr J, Arai AE et al. Ionizing Radiation in cardiac imaging. a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention. Circulation 119, 1056-1065 (2009).